BBI’s Biocapacitance Device Reduces Pressure Injury Incidence By 90% (weighted) in Acute Care Settings, Study Shows

Data Presented at the 2020 NPIAP Annual Conference

Houston, TX—February 27, 2020—Data presented at the 2020 National Pressure Injury Advisory Panel (NPIAP) Annual Conference showed utilizing a Biocapacitance device to alert clinicians of patients at increased risk of a pressure injury (PI) up to five days* before changes were visible on the skin[ii], reduced the hospital-acquired pressure injury incidence rates by 90% (weighted) in 26 acute care centers. The abstract was authored by BBI LLC (Bruin Biometrics).

In the study, 1,952 patients in acute care settings were scanned with the device daily on the heels and sacrum as an adjunct to standard of care. Overall, 73 percent of the acute care settings reported zero hospital-acquired pressure injuries.

“Hospital-acquired pressure injuries continue to be pernicious ‘never-events’ that cause patient harm and hospital liability, even though there is now enough scientific evidence that indicate that the majority can be preventable. These data show that by using BBI’s handheld, wireless device as an adjunct to local care practices – and importantly, without any additional preventative equipment or staffing— prevention in at-risk patients is possible and was achieved,” said Martin Burns, BBI CEO.

Each year, the U.S. healthcare system spends $26.8 billion on pressure injuries,[iii] with ~2.5m patients in the US developing a pressure injury each year.[iv]

“If acute care settings are looking to reduce their pressure injury incidence rate, reduce their liability and their bottom line, then integrating a device like BBI’s Provizio™ SEM Scanner into a prevention program should be an easy decision,” Burns added. “Prevention can finally be made real without any additional staffing or preventative equipment besides a simple, wireless handheld device that can help assess risk before pressure injuries are visible on the skin.”

About BBI LLC (Bruin Biometrics)

BBI LLC (Bruin Biometrics), is a pioneer in modernizing health care with biometric sensor technology for early identification and monitoring of chronic, preventable conditions in collaboration with clinicians.

BBI’s work has been recognized with a Frost & Sullivan New Product Innovation Award and a Health Service Journal Best Product or Innovation for Patient Safety Award.

BBI is based in Los Angeles and maintains a European office in Manchester, UK.

For additional information, visit www.sem-scanner.com. Follow BBI on Twitter at https://twitter.com/bruinbiometrics.

* Median
________________________________

[i] Wood Z., et al. (2020). Reducing Pressure Injury (PI) Incidence through the Introduction of Technology. Accepted and Presented at NPIAP, Houston, US

[ii] Okonkwo H., et al. (2020). A blinded clinical study using a subepidermal moisture biocapacitance measurement device for early detection of pressure injuries. Wound Repair and Regeneration 1-11https://do.org/10.1111/wrr.12790

[iii] Padula W. et al. (2019). The national cost of hospital-acquired pressure injuries in the United States. International Wound Journal, 1-7

[iv] Berlowitz D. et al. (2012). Agency for Healthcare Research and Quality (AHRQ). Preventing Pressure Ulcers in Hospitals. A Toolkit for Improving Quality of Care. [online] Available at: https://www.ahrq.gov/professionals/systems/hospital/pressureulcertoolkit/putool1.html (Accessed 7 April 2018)